October 2012 Issue of MMM

October 2012 Issue of MMM

October 2012 issue

Editor's Desk

The greatest intentions

There is no way that each year more than a third of the industry is job hunting

Features

2012 Career & Salary Survey: Checkmate

The job cuts haven't stopped. But here's the good news: average salaries are up, job satisfaction is holding steady, and execs seem to be valuing ...

Career Issue 2012: The Talent Score

What if analytics could help predict when one of your staffers needs a growth test, a new career-path option or just some coaching? Tanya Lewis ...

Career Issue 2012: Chutes & Ladders

Seek the next rung. Take the plunge. Most of all, these eight senior healthcare execs advise, enjoy the ride. As told to Marc Iskowitz

Leadership Exchange: Pact With the Payer

How can Marketing and Managed Markets evolve an already complex relationship to meet the new demands of payers? Our expert panel, led by James Chase, ...

Headliner: Full plate for Pfizer oncology chief

Andy Schmeltz, President, US Oncology Business Unit, Pfizer

Antidote

Antidote: Sleeping aids

On the whole, Ambien and the other medicines in its group are well tolerated and help many people

In Focus

Analysis sounds alarm on pipeline output

A Bernstein Research report shows that, essentially, "Pipeline success rates across all phases of development have been slowly worsening or at best staying flat, depending ...

Professional Marketing

Oncologists shut door on reps: study

The drug industry may be shifting its attention to specialty drugs, but data shows that detailing pressure and pharmaceutical rep access are still much higher ...

Million Hearts enlists pharmacists to battle hypertension

Pharmacists are the latest recruits in the government's push to reduce the nation's risk of heart disease.

Professional Marketing briefs: October 2012

News on Content Marketing Institute, MedCityNews.com, Sanofi and the FDA

Med Ed Report

Docs in the dark about opioid REMS

Only 35% of physicians are aware of the FDA's class-wide safety plan for extended-release and long-acting opioids, a survey showed.

Sunshine could chill CME attendance

A physician survey found that docs are reconsidering their participation in industry-sponsored CME, fearful that their inclusion in Sunshine Act databases as having received payments ...

J&J, states settle on Risperdal

As part of a $181-million settlement with states to resolve charges of improper marketing and advertising, Johnson & Johnson agreed to stop several practices regarding ...

Med Ed Report briefs: October 2012

News on New England Journal of Medicine, MedBiquitous, Physicians' Education Resource, CECity and CBI

Professional Media

JAMA racks up big-league numbers

The size of JAMA's audience is giving the Super Bowl a run for its money

Trust in digital varies among health professionals: study

Health marketing communications firm Enspektos did a deep dive into desktop and media habits and found that who you are in the healthcare industry plays ...

Professional Media briefs: October 2012

News on Wolters Kluwer, Contraception magazine, the Crohn's and Colitis Foundation and Elsevier

Partner Forum

Can 'performance' pricing pay off?

Many media agencies now use pay-for-performance compensation. It calls for tying media efforts to trackable metrics. What metrics should be used, and how can an ...

Digital Media

WedMD gets star-powered redesign

WebMD executed a cross-platform magazine redesign with a more visual and celeb-centric new look. It's the first refresh for WebMD the Magazine since its debut ...

For oncologists, just a few clicks to 'organized wisdom'

A new tool on MedPage­Today.com promises to streamline the research process for physicians. Called the Oncology Next Tool, it can deliver patient-focused information just by ...

Digital Media briefs: October 2012

News on Doximity, Eli Lilly and InTouch Solutions

Consumer Marketing

Ads for OTC switches skip risk info, study finds

A study of advertising for drugs that have made the switch from prescription to over-the-counter status found that the presentation of risk information plummeted once ...

DDR on DTC: Cialis

Eli Lilly's commitment to the positioning and branding for Cialis has remained refreshingly consistent

Merck site will 'tackle' diabetes

Merck and ESPN's Mike Golic kicked off a diabetes education program in August to offer patients help navigating a type-2 diabetes diagnosis.

Marketing Research

Vantage Point: Addressing 'opportunity leakage'

Prescribing remains important, but it's half the picture: pharma's ultimate customer is the patient

Pharma MR budgets on the mend, survey says

Budgets of pharmaceutical marketing research teams are starting to recover, one analyst firm found.

Hicks named to WorldOne board

Healthcare marketing research firm WorldOne expanded its board of directors with the addition of Kerry Hicks, the founder and former CEO of HealthGrades

Agency Business

Publicis forms Razorfish Healthware

The healthcare communications arm of Publicis Group is bringing two of its digital agencies together in a move designed to bolster them against the tide ...

Draftfcb acquires New York pharma shop Hudson Global

Draftfcb Healthcare has bought Tarrytown, NY-based drug marketing shop Hudson Global.

Agency Business briefs: October 2012

News on Roska Healthcare Advertising, Pacific Communications, Havas Worldwide Health and Rosetta

Washington Insider

As I See It: Dealing With the Mandate

Part D is the Michael Phelps of healthcare reform—providing a roadmap toward real evolution

Feds add a new tool to fight fraud at drug firms

Used for the first time in the recent $3 billion healthcare fraud settlement with Glaxo­SmithKline (GSK), a new enforcement tool has joined the federal government's ...

Viewpoint

A critical opportunity in the healthcare debate

The American people are still trying to get their heads around what the Affordable Care Act means to them

Private View

Private View: Making good use of the 3 P's

Ads that engage and hold a patient employ the 3 P's: Personification, Personalization, and Projection.

Upward Move

Upward Move: Gabrielle Pastore

Gabrielle Pastore, Global Strategic Commercial Innovation Vice President, Cadient Group

At Work With

At Work With: Rick Conrad

Rick Conrad, Associate Creative Director/Art, AbelsonTaylor

Back Talk

Rise, fall of the 'Mad Men' age

Project timelines that were once measured in months are now compressed into days

Email Newsletters